Clinical Trial Update: A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum [Phase 2]

View source ↗

Summary

Phase 2 study of DS-1211b in individuals with Pseudoxanthoma Elasticum completed, with results posted on 2024-12-31.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudoxanthoma Elasticum

Drugs mentioned

• DS-1211b

Snippet

Sponsor: Daiichi Sankyo | Conditions: Pseudoxanthoma Elasticum | Phase 2 | Status: COMPLETED | Results posted: 2024-12-31